Audrey Sternberg | Authors


Breast Cancer Testing May Benefit from the Multi-Omics Approach Over Biomarker Assessment Alone

April 13, 2021

For patients with metastatic breast cancer, research suggests that utilizing a multi-omics approach to personalized therapy that incorporates information about actionable oncogenic drivers with critical biological data may be feasible and better than DNA sequencing alone.

Paclitaxel/Cisplatin for HIPEC During Debulking Correlates With Better Outcomes for Advanced Epithelial Ovarian Cancer

March 26, 2021

In women with advanced epithelial ovarian cancer treated in a single-institution study at the Cleveland Clinic, the addition of paclitaxel to cisplatin for hyperthermic intraperitoneal chemotherapy during interval debulking surgery was associated with improved oncologic outcomes compared with cisplatin alone.

Lenvatinib Plus Everolimus Signals Efficacy After Immunotherapy in ccRCC

February 11, 2021

In patients with clear cell renal cell carcinoma who had been treated with an immune checkpoint inhibitor in prior lines of therapy, lenvatinib in combination with everolimus was found to be safe and effective.